Trial intelligence / Profile preview

Tranexamic acid for reducing post-operative periorbital ecchymosis and edema in upper blepharoplasty

TCTR20220624007Phase 1Unknown

Sponsor
Faculty of Medicine, Khon Kaen University
Start
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial of tranexamic acid in eyelid edema and periorbital hematoma (2 arms), sponsored by Faculty of Medicine, Khon Kaen University. Primary endpoints: Post-operative periorbital ecchymosis and Post-operative periorbital edema. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

eyelid edemaperiorbital hematoma

Beyond the preview

Go deeper on TCTR20220624007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20220624007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call